Stay updated on Dapagliflozin Safety & Efficacy in Asian T2DM Clinical Trial
Sign up to get notified when there's something new on the Dapagliflozin Safety & Efficacy in Asian T2DM Clinical Trial page.

Latest updates to the Dapagliflozin Safety & Efficacy in Asian T2DM Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page’s footer and related-topic area were updated, including the listed “Type 2 diabetes” related resources and a change to the site revision version. No study-level information (design, outcomes, eligibility, or status) appears to have been altered.SummaryDifference0.2%

- Check24 days agoChange DetectedRemoved the related topics 'Type 2 diabetes' and 'MedlinePlus Genetics' from the page's related topics section.SummaryDifference0.2%

- Check46 days agoChange DetectedRevision metadata updated from v3.4.3 to v3.5.0 on the page.SummaryDifference0.1%

- Check60 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check82 days agoChange DetectedAdded the keyword Type 2 Diabetes and the related topic MedlinePlus Genetics; updated revision tags from v3.4.1 to v3.4.2.SummaryDifference0.2%

- Check89 days agoChange DetectedRevision: v3.4.1 updated on the page, replacing v3.4.0; no changes to content or functionality observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Dapagliflozin Safety & Efficacy in Asian T2DM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapagliflozin Safety & Efficacy in Asian T2DM Clinical Trial page.